IP Library Granted Patent US 7,399,485
Granted Patent B1
US 7,399,485 · App. 09/403,429 · Granted Jul 15, 2008

Rapidly Disintegrable solid preparation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,399,485
App. No.
09/403,429
Granted
Jul 15, 2008
Kind
B1
Abstract

A rapidly disintegrable solid preparation which comprises (i) a pharmacologically active ingredient, (ii) a sugar and (iii) a low-substituted hydroxypropylcellulose having 5% by weight or more to less than 7% by weight of hydroxypropoxyl group. The rapidly disintegrable solid preparation has fast disintegrability, suitable strength and no roughness.

Claims (22)

1. A method for preparing a rapidly disintegrable tablet comprising

producing fine granules containing lansoprazole, said granules having a core and at least one layer coating said core,

blending said fine granules with a sugar and a low-substituted hydroxypropylcellulose having 5% to less than 7% by weight of hydroxypropoxyl groups, said sugar is an amount of in an amount of 5 to 97 parts by weigh per 100 parts by weight of the rest of the tablet other than the fine granules and

molding to obtain a tablet,

wherein said tablet is bucally dissolved in from about 5 to about 50 seconds.

2. A method for improving fast disintegrability of a lansoprazole comprising

adding low-substituted hydroxypropylcellulose having 5% to less than 7% by weight of hydroxypropoxyl groups and sugar in combination with fine granules containing lansoprazole to obtain an improved tablet;

wherein said sugar is added in an amount of 5 to 97 parts by weight per 100 parts by weight of the rest of the tablet other than said fine granules, and

wherein said improved tablet is bucally dissolved in from about 5 to about 50 seconds.

3. The method of claim 1 , wherein said tablet is bucally dissolved in from about 5 to about 40 seconds.

4. The method of claim 1 , wherein said tablet is bucally dissolved in from about 5 to about 35 seconds.

5. The method of claim 1 , wherein said sugar is a sugar alcohol.

6. The method of claim 1 , wherein said sugar is mannitol or erythritol.

7. The method of claim 2 , wherein said tablet is bucally dissolved in from about 5 to about 40 seconds.

8. The method of claim 2 , wherein said tablet is bucally dissolved in from about 5 to about 35 seconds.

9. An orally disintegrabic tablet comprising:

fine granules containing lansoprazole, said granules having a core and at least one layer coating said core;

a sugar wherein said sugar is in an amount of 5 to 97 parts by weight of the rest of the tablet other than said fine granules; and

a low-substituted hydroxypropylcellulose having 5 to 7% by weight of hydroxypropoxyl groups;

wherein said low-substituted hydroxypropyl cellulose is separate from said fine granules in said tablet;

wherein said tablet is improved in chalky taste and has no roughness and wherein said tablet is bucally dissolved in from about 5 to about 50 seconds.

10. The tablet of claim 9 wherein said fine granules are enteric-coated fine granules.

Assignments (2)
CHANGE OF NAME Recorded Jun 2, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 018917/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 1999
From: SHIMIZU, TOSHIHIRO; SUGAYA, MASAE; NAKANO, YOSHINORI
To: TAKEDA CHEMICAL INDUSTRIES, LTD.
Reel/Frame 010459/0640 →